Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KBTBD6 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
mRNA | DCT | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
mRNA | HOMER3 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
mRNA | PRRC2C | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
mRNA | ESRP2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
mRNA | RNF185 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
mRNA | CYB561A3 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
mRNA | TP73 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.009 |
mRNA | PSG1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
mRNA | TMEM86A | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |